查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1877462

即时凝血检测市场：依检测类型、技术、最终用户、国家及地区划分－全球产业分析、市场规模、市场占有率及2025-2032年预测

Point-of-Care Coagulation Testing Market, By Test Type, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 390 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年即时凝血检测市场规模为 27.9878 亿美元，从 2025 年到 2032 年将以 6.5% 的复合年增长率成长。

床边凝血检测 (POCCT) 透过提供快速的床边血液凝固分析，协助即时、数据驱动的临床决策，进而革新医疗保健产业。在急诊、手术和出血性疾病等情况下，对快速、准确的凝血诊断的需求日益增长，以实现个人化的患者护理。连接性、小型化和人工智慧整合的持续创新推动了市场成长。此外，市场正经历着向复杂黏弹性检测的显着趋势，这种检测能够提供全面的血栓特征，从而改善创伤和手术预后。居家抗凝血监测的推广应用蕴藏着巨大的成长机会，使慢性病患者更容易管理治疗。然而，当检测在中心实验室之外进行时，如何维持一致且严格的品质控制仍然是市场面临的挑战。

即时凝血检测市场－市场动态

心血管疾病日益普遍

在全球范围内，心血管疾病，例如深部静脉栓塞、中风和心房颤动，是导致死亡和发病的主要原因。根据世界卫生组织（世卫组织）2025年7月发布的资料，心血管疾病是全球首要的死因。 2022年，全球约有1,980万人死于心血管疾病，约占总死亡人数的32%。其中，心臟病发作和中风占85%。此外，在2021年因非传染性疾病导致的1,800万例过早死亡（70岁以下）中，至少有38%是由心血管疾病造成的。因此，为了预防出血或血栓形成等潜在的致命副作用，有效的抗凝血治疗需要常规监测凝血参数，包括凝血酶原时间（PT/INR）和活化凝血时间（ACT）。然而，传统实验室检测的集中式基础设施和较长的周转时间可能会导致重要的治疗选择被延误。床边凝血检测（POC​​凝血检测）解决了这些难题，可在几分钟内于患者床边、手术室、急诊室甚至家中提供检测结果。除了减少住院次数外，这也有助于提高患者的依从性，尤其对于长期服用抗凝血药物的患者。

即时凝血检测市场区隔分析：

全球即时凝血检测市场按检测类型、技术、最终用户和地区进行细分。

根据检测类型，市场可分为五大类：凝血酶原时间 (PT/INR) 检测、活化凝血时间 (ACT) 检测、活化部分凝血活酶时间 (aPTT) 检测、黏弹性检测（如 TEG、ROTEM 等）以及其他特殊凝血检测。 PT/INR 用于监测外源性凝血途径和华法林治疗，ACT 用于指导高剂量肝素治疗，aPTT 用于检测内源性凝血途径和肝素治疗，TEG/ROTEM 用于分析血栓动力学，其他检测则针对特定疾病。

根据技术，市场可分为三大类：光学技术、机械技术和电化学技术。光学技术透过测量光线变化或模式来检测凝血；机械技术透过评估血液黏度或流动情况来指示血栓形成；电化学技术则透过检测凝血过程中的电变化来判断凝血情况。

即时凝血检测市场—地域洞察

北美市场占据主导地位，这主要得益于先进的医疗基础设施、广泛的应用以及出血性疾病的高发生率。此外，北美地区对快速诊断、抗凝血治疗管理以及医疗保健领域的大力投入等因素，也使得床边凝血检测得到广泛应用。英国和其他西方国家在欧洲市场正经历快速成长，这得益于政府的鼓励性措施、慢性病自我监测的普及以及对快速可靠监测的需求，尤其是在抗凝血治疗和手术方面。亚太地区预计将成为成长最快的地区，这主要得益于医疗保健覆盖范围的扩大、心血管凝血检测的强制性要求以及需要快速管理出血和血栓性疾病的患者群体不断扩大。拉丁美洲的床边凝血检测市场也在稳定成长，这得益于疾病快速检测和有效管理的投资。中东和非洲的需求也在不断增长，这主要归功于卒中管理项目的开展以及专科中心对基于试剂盒的凝血检测的日益重视。

即时凝血检测市场－竞争格局：

即时凝血检测 (POC) 市场竞争激烈且成长迅速，其主要驱动力是临床和家庭环境中对快速、准确的凝血评估日益增长的需求。主要参与者包括罗氏 (F. Hoffmann-La Roche Ltd.)、雅培 (Abbott Laboratories)、西门子医疗 (Siemens Healthineers)、希森美康 (Sysmex Corporation) 和 Werfen，它们都致力于透过微流控、生物感测器和人工智慧整合等先进技术来扩展产品组合。这些公司在研发、创新和策略合作方面投入巨资，以提高设备的准确性、便携性和连接性，从而实现与医疗保健系统的无缝整合。例如，2022 年 1 月，罗氏宣布在部分国家推出 CE 认证的 cobas pulse 系统。这款新系统代表了罗氏诊断最新一代互联即时解决方案，专为专业血糖管理而设计。此外，该市场呈现半整合结构，少数几家主导製造商占据了相当大的市场份额，而众多规模较小的公司则在细分市场中竞争。

目录

第一章：即时凝血检测市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 即时凝血检测市场概览（依检测类型划分）
    • 即时凝血检测市场技术概览
    • 按最终用户分類的即时凝血检测市场概览
    • 各国即时凝血检测市场概况
    • 即时凝血检测市场区域概览
  • 竞争洞察

第三章：即时凝血检测市场主要趋势

  • 即时凝血检测市场驱动因素
    • 市场驱动因素的影响分析
  • 即时凝血检测市场限制因素
    • 市场限制因素的影响分析
  • 即时凝血检测市场机会
  • 即时凝血检测市场未来趋势

第四章：即时凝血检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：即时凝血检测市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：即时凝血检测市场概况

  • 即时凝血检测市场占有率分析，2024年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：即时凝血检测市场－依检测类型划分

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 凝血酶原时间（PT/INR）检测
    • 活化凝血时间 (ACT) 检测
    • 活化部分凝血酶原时间 (aPTT) 检测
    • 黏弹性测试（TEG、ROTEM 等）
    • 其他特殊凝血试验

第八章：即时凝血检测市场－依技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 光学技术
    • 机械技术
    • 电化学技术

第九章：即时凝血检测市场－依最终使用者划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 门诊手术中心（ASC）
    • 诊断实验室
    • 家庭护理机构
    • 其他的

第十章：即时凝血检测市场－依地域划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美即时凝血检测主要生产商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（依测试类型划分）
    • 北美市场规模及预测（依技术划分）
    • 北美市场规模及预测（依最终用户划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲即时凝血检测主要製造商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（依测试类型划分）
    • 欧洲市场规模及预测（依技术划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区即时凝血检测主要生产商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依测试类型划分）
    • 亚太市场规模及预测（依技术划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲即时凝血检测主要生产商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（按测试类型划分）
    • 拉丁美洲市场规模及预测（依技术划分）
    • 拉丁美洲市场规模及预测（按最终用户划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲即时凝血检测主要生产商
    • MEA市场规模及预测（依国家/地区划分）
    • MEA市场规模及预测（依测试类型划分）
    • MEA市场规模及预测（依技术划分）
    • MEA市场规模及预测（依最终用户划分）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十一章：主要供应商分析－即时凝血检测产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Siemens Healthineers
    • Abbott Laboratories
    • Sysmex Corporation
    • Werfen
    • Danaher Corporation
    • Medtronic
    • HemoSonics, LLC
    • Danaher Corporation
    • Trinity Biotech
    • F. Hoffmann-La Roche Ltd

第十二章：360度AnalystView

第十三章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5718

Point-of-Care Coagulation Testing Market size was valued at US$ 2,798.78 Million in 2024, expanding at a CAGR of 6.5% from 2025 to 2032.

Point-of-Care Coagulation Testing (POCCT) is revolutionizing healthcare by providing rapid, bedside blood clotting analysis that enables immediate, data-driven clinical decisions. The rising demand for fast, accurate coagulation diagnostics to personalize patient care in emergencies, surgeries, and bleeding disorders, supported by continuous innovation in connectivity, miniaturization, and AI integration is boosting market growth. Additionally, the market is witnessing a significant trend toward sophisticated viscoelastic testing that offers a comprehensive clot profile, improving trauma and surgical outcomes. A major growth opportunity lies in expanding home-based anticoagulant monitoring, empowering patients with chronic conditions to manage therapy conveniently. However, the market faces challenges in maintaining consistent and rigorous quality control when testing occurs outside centralized laboratory settings.

Point-of-Care Coagulation Testing Market- Market Dynamics

Growing prevalence of cardiovascular diseases

Globally, cardiovascular diseases such deep vein thrombosis, stroke, and atrial fibrillation are leading causes of death and morbidity. According to data published in July 2025, by World Health Organization (WHO), globally, cardiovascular diseases (CVDs) constitute the primary cause of mortality. About 19.8 million deaths worldwide in 2022 were attributed to CVDs, accounting for about 32% of the total number of deaths. Heart attacks and strokes were the cause of 85% of these fatalities. Moreover, CVDs were responsible for at least 38% of the 18 million premature deaths (those under 70) that occurred in 2021 as a result of noncommunicable diseases. Thus, in order to prevent potentially fatal side effects like bleeding or thrombosis, effective anticoagulation therapy necessitates routine monitoring of clotting parameters including Prothrombin Time (PT/INR) and Activated Clotting Time (ACT). However, centralized infrastructure and longer turnaround times associated with traditional laboratory testing may cause important treatment choices to be postponed. These obstacles are addressed by POC coagulation tests, which provide results in a matter of minutes at the patient's bedside, operating room, emergency hospital, or even their home. In addition to decreasing hospitalizations, this also improves patient adherence, particularly for long-term anticoagulant users.

Point-of-Care Coagulation Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2025-2032)

Based on Test Type segmentation, Prothrombin Time (PT/INR) Testing is predicted to show maximum market share in the year 2024

Based on Technology segmentation, Optical Technology is the leading Technology in 2024

Based on End User segmentation, Hospitals & Clinics is the leading Technology in 2024

On the basis of region, North America is the leading revenue generator in 2024

Point-of-Care Coagulation Testing Market- Segmentation Analysis:

The Global Point-of-Care Coagulation Testing Market is segmented on the basis of Test Type, Technology, End User, and Region.

The market is divided into five categories based on Test Type: Prothrombin Time (PT/INR) Testing, Activated Clotting Time (ACT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Viscoelastic Testing (TEG, ROTEM, etc.), and Other Specialized Coagulation Tests. PT/INR monitors extrinsic pathway and warfarin, ACT guides high-dose heparin, aPTT checks intrinsic pathway and heparin, TEG/ROTEM analyze clot dynamics, others target specific disorders.

The market is divided into three categories based on Technology: Optical Technology, Mechanical Technology, and Electrochemical Technology. Optical technology measures light changes or patterns to detect clotting; mechanical technology assesses blood viscosity or movement to indicate clot formation; electrochemical technology detects electrical changes during coagulation.

Point-of-Care Coagulation Testing Market- Geographical Insights

North America dominates the market, driven by advanced healthcare infrastructure, widespread adoption, and a high prevalence of bleeding disorders. Additionally, North America exhibits widespread adoption of point-of-care coagulation testing due to the emphasis on rapid diagnosis, anticoagulant therapy management, and strong healthcare investments, among others. The UK and other Western nations are experiencing rapid growth in Europe as a result of encouraging government measures, increasing adoption of self-monitoring for chronic conditions, and demand for rapid, reliable monitoring, especially in anticoagulation therapy and surgery. Asia-Pacific is expected to witness the fastest growth, fueled by expanding healthcare access, mandates for cardiovascular clotting tests, and larger patient populations requiring rapid management of bleeding and thrombotic disorders. The Latin American point-of-care coagulation testing market is expanding steadily, owing to investment in rapid disease detection and effective management. Middle East and Africa, show rising demand, due to stroke management programs and an increasing focus on cartridge-based coagulation tests in specialty centers.

Point-of-Care Coagulation Testing Market- Competitive Landscape:

The point-of-care (POC) coagulation testing market is highly competitive and rapidly growing, driven by increasing demand for quick, accurate clotting assessments in clinical and home settings. Key players include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, and Werfen, all focusing on expanding product portfolios through advanced technologies such as microfluidics, biosensors, and AI integration. These companies invest significantly in research, innovation, and strategic collaborations to enhance device accuracy, portability, and connectivity, enabling seamless integration with healthcare systems. For instance, in January 2022, F. Hoffmann-La Roche Ltd has announced the launch of the cobas pulse system in select countries with CE Mark approval. This new system represents Roche Diagnostics' latest generation of connected point-of-care solutions designed specifically for professional blood glucose management. Additionally, the market is characterized by a semi-consolidated structure, with a few dominant manufacturers holding substantial shares while numerous smaller companies compete in niche segments.

Recent Developments:

In July 2024, Werfen introduced GEM Premier 7000 with Intelligent Quality Management 3 (iQM3). The GEM Premier 7000 with iQM3 represented a breakthrough in blood gas testing, and offered hemolysis detection for first time at the point-of-care (POC).

In March 2023, Siemens Healthineers and Sysmex Corporation have established a global Original Equipment Manufacturer (OEM) agreement to supply hemostasis instruments and reagents. The strengthened collaboration leveraged their 25-year partnership to improve patient outcomes by advancing hemostasis testing technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • Abbott Laboratories
  • Sysmex Corporation
  • Werfen
  • Danaher Corporation
  • Medtronic
  • HemoSonics, LLC
  • Danaher Corporation
  • Trinity Biotech
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prothrombin Time (PT/INR) Testing
  • Activated Clotting Time (ACT) Testing
  • Activated Partial Thromboplastin Time (aPTT) Testing
  • Viscoelastic Testing (TEG, ROTEM, etc.)
  • Other Specialized Coagulation Tests

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Home Care Settings
  • Others

GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Point-of-Care Coagulation Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Point-of-Care Coagulation Testing Market Snippet by Test Type
    • 2.1.2. Point-of-Care Coagulation Testing Market Snippet by Technology
    • 2.1.3. Point-of-Care Coagulation Testing Market Snippet by End User
    • 2.1.4. Point-of-Care Coagulation Testing Market Snippet by Country
    • 2.1.5. Point-of-Care Coagulation Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Point-of-Care Coagulation Testing Key Market Trends

  • 3.1. Point-of-Care Coagulation Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Point-of-Care Coagulation Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Point-of-Care Coagulation Testing Market Opportunities
  • 3.4. Point-of-Care Coagulation Testing Market Future Trends

4. Point-of-Care Coagulation Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Point-of-Care Coagulation Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Point-of-Care Coagulation Testing Market Landscape

  • 6.1. Point-of-Care Coagulation Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Point-of-Care Coagulation Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Prothrombin Time (PT/INR) Testing
    • 7.1.3. Activated Clotting Time (ACT) Testing
    • 7.1.4. Activated Partial Thromboplastin Time (aPTT) Testing
    • 7.1.5. Viscoelastic Testing (TEG, ROTEM, etc.)
    • 7.1.6. Other Specialized Coagulation Tests

8. Point-of-Care Coagulation Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Optical Technology
    • 8.1.3. Mechanical Technology
    • 8.1.4. Electrochemical Technology

9. Point-of-Care Coagulation Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Home Care Settings
    • 9.1.6. Others

10. Point-of-Care Coagulation Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Point-of-Care Coagulation Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Point-of-Care Coagulation Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Point-of-Care Coagulation Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Point-of-Care Coagulation Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Point-of-Care Coagulation Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point-of-Care Coagulation Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Siemens Healthineers
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Sysmex Corporation
    • 11.2.4. Werfen
    • 11.2.5. Danaher Corporation
    • 11.2.6. Medtronic
    • 11.2.7. HemoSonics, LLC
    • 11.2.8. Danaher Corporation
    • 11.2.9. Trinity Biotech
    • 11.2.10. F. Hoffmann-La Roche Ltd

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us